Virdev Intermediates is an API and finished-dose manufacturer based in India. It holds one active US drug master file and one valid CEP across a filed portfolio of 4 molecules. Its GMP standing is certified by EMA and CDSCO (India). Customs aggregates show $23K of exports covering 1 molecule to 1 destination in 2025.
| Site | FDA FEI |
|---|---|
| Surat, India | 3033605590 |
| Surat, India | Not on file |
| Surat, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Lymecycline | EDQM | 1 |
| Sugammadex | SFDA (Saudi Arabia) | 1 |
| Vardenafil | SFDA (Saudi Arabia) | 1 |
| Vonoprazan | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 7 | 2 |
| EMA | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $21K | 1 |
| 2025 | Not reported | $23K | 1 |
| 2024 | Not reported | $112K | 2 |
| 2023 | Not reported | $39K | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Virdev Intermediates comes back tiered against every other supplier able to file there.
Start for free